GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of stalled for 16 weeks at 0.5mg and I refuse to panic this time — 18 comments in the full submission. View in context.
305

stalled for 16 weeks at 0.5mg and I refuse to panic this time

Paperbranch of 4 comments

gastric emptying. That is the whole post, but I will justify it. Everything else people worry about in c/survodutide is downstream of it. Titration speed, early fullness, the endless dose arguments — most of it resolves if you sort gastric emptying out first, and almost nobody does. I say this having got it wrong for…

Read the full submission and all 18 comments →

This branch

4 comments, started 7 months ago
u/rafael_ostergaard10 points·7 months ago

The half-life is 13 hours, which means week 13 is genuinely still ramp-up. Week 40 is steady state.

replysharereportpermalink
u/split_dose_sceptic8 points·7 months ago

Disagree. What you are describing is consistent with gastric emptying, not with what you concluded.

replysharereportpermalink
u/ireland_drugs_pay2 points·7 months ago

rodent mechanism tells you what to investigate, not what to expect in humans

replysharereportpermalink
u/bilal_osei1 point·7 months ago·edited

do not extrapolate rodent data to human dosing without saying so

replysharereportpermalink

← back to the whole thread

About c/glp1science

The mechanism layer: incretin physiology, receptor distribution, gastric emptying, central appetite signalling, glucagon-receptor contribution, amylin co-agonism, and the pharmacokinetics that make weekly dosing possible. Papers get cited by journal and year or they get a [needs source] reply.

50kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1science rules
  1. Cite the paper: journal, year, first author. Links optional, citation mandatory.
  2. Mechanistic speculation is welcome if flaired as speculation.
  3. No extrapolating rodent data to human dosing without saying that is what you are doing.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.